Flosonics Medical Secures $20 Million USD in Series C Funding Led by New Leaf Venture Partners to Accelerate Growth

SUDBURY, Ontario, March 19, 2024 /Business Wire/ — Flosonics Medical, a leader in wearable medical ultrasound, today announced its Series C financing, raising $20 million USD. The round was led by New Leaf Venture Partners, with participation from previous investors Arboretum Ventures, Genesys Capital, and iGan Partners. This new funding will support Flosonics as the company continues to innovate and […]

Read more

Crowning Achievement: Flosonics Medical Receives the Award as a Rising Star at the 5th Annual Digital Health Hub Foundation Awards hosted at HLTH

Las Vegas, Nevada, October 9, 2023 — Flosonics Medical is thrilled to declare its selection as a Rising Star of the Digital Health Awards, presented by The Digital Health Hub Foundation, and hosted at the renowned HLTH global healthcare conference. Flosonics Medical has secured the coveted Digital Health Hub Foundation Award in the Rising Stars […]

Read more

Riverside University Health System to Implement FloPatch by Flosonics, Revolutionizing Precision Fluid Management in Sepsis Care

RIVERSIDE, Calif., September 21, 2023 /Business Wire/ — Riverside University Health System is proud to announce the implementation of FloPatch by Flosonics Medical. As a pioneer in adopting new, ground-breaking medical technology, Riverside is making a significant leap forward in healthcare innovation, particularly in the life-saving area of sepsis management.  FloPatch is a revolutionary tool […]

Read more

El Camino Health is first in the world to adopt FloPatch advanced ultrasound technology for sepsis management

MOUNTAIN VIEW, Calif., March 14, 2023 /PRNewswire/ — El Camino Health is the first health system in the world to adopt FloPatch, an innovative new technology that monitors blood flow in real time. Developed by Flosonics Medical, FloPatch is the world’s first wireless, wearable Doppler ultra-sound system that helps clinicians better manage intravenous (IV) fluid therapy earlier in the sepsis […]

Read more

Flosonics Medical Announces Publication of STOP FLOODING Observational Study Employing Wireless, Wearable Doppler Ultrasound

SUDBURY, Ontario–(BUSINESS WIRE)–Flosonics Medical, a company dedicated to improving patient care with wireless, wearable ultrasound sensors, announced today the publication of an observational study in the Journal of Intensive Care. The results provide strong evidence for the use of FloPatch® to help prevent the over-prescription of IV fluids in adult patients with sepsis, septic shock and other […]

Read more

FloPatch featured in Frontiers in Medical Technology’s Highlights in Diagnostic and Therapeutic Devices

The collection aims to bring high-quality research in the field of Diagnostic and Therapeutic Devices into the spotlight and further promote it as part of a prestigious collection that includes other key opinion leaders.

Read more

Flosonics Medical receives over $1.5 million through the province’s Ontario Together Fund

The investment will allow Flosonics Medical to scale up the manufacturing and distribution of cutting-edge medical solutions while strengthening the province’s pandemic supply chain

Read more

Flosonics Medical graduates from Fogarty Innovation’s prestigious Company Accelerator Program

The program assisted Flosonics Medical in developing a strong market entry plan as it moves toward the commercial launch of its wearable, wireless Doppler ultrasound system

Read more

New study finds that carotid Doppler ultrasonography correlates with stroke volume in a human model of hypovolemia and resuscitation

An analysis of 48,570 cardiac cycles revealed that monitoring stroke volume change via carotid Doppler might support the diagnosis and management of evolving hypovolemia

Read more